GleamWall
中文EN

ORGO Organogenesis Holdings Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1661181 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-24.3%
TTM net income YoY-13,567.9%
TTM EPS YoY-1,400.0%
Revenue 3-yr CAGR-7.8%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-24.5%
Net margin-38.4%
FCF margin-0.0%
EBITDA margin-20.0%

Returns

ROE-72.2%
ROA-30.8%
ROIC (approx.)-47.0%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets28.8%
Debt / equity0.00x
Current ratio3.32x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.08x
Accruals ratio-33.2%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$564.17M$482.04M
Cost of revenue—$115.74M
Gross profit—$366.30M
R&D expense$44.54M$50.27M
SG&A expense$326.24M$294.51M
Operating income$44.69M-$1.28M
Interest expense-$2.28M$1.54M
Pretax income$46.97M-$2.81M
Income tax$9.94M-$3.67M
Net income$37.03M$861,000
EBITDA$59.97M$12.34M
EPS (basic)0.16-0.01
EPS (diluted)0.15-0.01
Weighted avg. shares (diluted)130.25M131.67M
Balance sheet
Cash & equivalents$93.68M$136.15M
Receivables$217.45M$109.86M
Inventory$29.63M$26.22M
Current assets$362.19M$285.94M
PP&E, net$103.71M$89.13M
Goodwill$28.77M$28.77M
Intangibles$9.14M$12.47M
Total assets$598.73M$497.89M
Current liabilities$100.12M$77.48M
Total liabilities$164.81M$112.57M
Shareholders' equity$300.13M$262.90M
Shares outstanding126.95M125.73M
Cash flow statement
Operating cash flow-$10.31M$14.21M
Capital expenditure$14.15M$10.03M
Free cash flow-$24.46M$4.18M
Investing cash flow-$14.15M-$10.03M
Financing cash flow-$17.36M$27.64M
Depreciation & amortization$15.27M$13.62M
Stock-based compensation$13.30M$10.58M
Share buybacks—$25.48M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.